
Join to View Full Profile
2103 Cornell RdCleveland, OH 44106
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Miller is the Paul and Betsy Shiverick Professor of Immuno-Oncology and a physician-scientist at Case Western Reserve University School of Medicine and University Hospitals in Cleveland, OH. As a practicing pathologist and researcher, his work focuses on developing novel immunotherapy strategies for solid tumors, with a particular emphasis on brain cancers. Clinically, Dr. Miller is a Molecular Pathologist in the Genomic and Molecular Pathology at University Hospitals. Dr. Miller also leads a translational research lab that integrates advanced single-cell genomics, spatial transcriptomics and proteomics, and patient-derived tumor organoid modeling to better understand and target the immunosuppressive myeloid cells that contribute to immunotherapy resistance. His work has uncovered fundamental mechanisms of myeloid-driven immunosuppression in glioblastoma, paving the way for more effective immunotherapeutic approaches. Learn more at tymillerlab.org
Education & Training
- Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2018 - 2021
- Case Western Reserve University School of MedicineClass of 2018, MD, PhD
Certifications & Licensure
- OH State Medical License 2024 - 2026
- TX State Medical License 2024 - 2026
- MA State Medical License 2018 - 2024
- American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- Protocol for mitochondrial variant enrichment from single-cell RNA sequencing using MAESTER.Jonathan D Good, Ksenia R Safina, Tyler E Miller, Peter van Galen
STAR Protocols. 2025-03-21 - Programs, origins and immunomodulatory functions of myeloid cells in glioma.Tyler E Miller, Chadi A El Farran, Charles P Couturier, Zeyu Chen, Joshua P D'Antonio
Nature. 2025-02-26 - 1 citationsEvolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas.Jingyi Wu, L Nicolas Gonzalez Castro, Sofia Battaglia, Chadi A El Farran, Joshua P D'Antonio
Nature Cancer. 2025-01-01
Press Mentions
- Why Brain Cancer Is Often Resistant to ImmunotherapyFebruary 26th, 2025
Grant Support
- Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.CASE WESTERN RESERVE UNIVERSITY2023–2028
- Targeting epigenetic regulation to disrupt glioma stem cell maintenance.National Cancer Institute2014–2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: